Cargando…
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association
The European Society of Cardiology 2021 guideline on cardiovascular (CV) disease (CVD) prevention in clinical practice has major implications for both CV risk screening and kidney health of interest to primary care physicians, cardiologists, nephrol-ogists, and other professionals involved in CVD pr...
Autores principales: | Ortiz, Alberto, Wanner, Christoph, Gansevoort, Ron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972834/ https://www.ncbi.nlm.nih.gov/pubmed/36865018 http://dx.doi.org/10.1093/ckj/sfac199 |
Ejemplares similares
-
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association
por: Ortiz, Alberto, et al.
Publicado: (2022) -
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice
por: Gansevoort, Ron T., et al.
Publicado: (2016) -
The last pre-pandemic European Renal Association Registry report: age at start of kidney replacement therapy in Europe
por: Carriazo, Sol, et al.
Publicado: (2021) -
From WEDA to EDTA to ERA: 60 years of supporting European nephrology and counting
por: Wanner, Christoph
Publicado: (2022) -
European East–West divide in kidney disease: the need to understand the drivers of chronic kidney disease outcomes
por: Carriazo, Sol, et al.
Publicado: (2020)